Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

被引：0
|
作者：
Couto, Maria Eduarda [1 ]
Borges, Marina [1 ]
Bento, Maria Jose [1 ]
Daniela, Rita Calisto Marta [1 ]
Magalhaes, Marques [1 ]
Ajmal, Adil
Niklas, Nicolas [2 ]
Dushkin, Kirill [2 ]
MacDougall, Finaly [2 ]
Wolf, Andrea [3 ]
mShabid, Shabana [3 ]
vonMetzler, Ivana [4 ]
机构：
[1] Portuguese Oncol Inst Porto, Porto, Portugal
[2] IQVIA Ltd, London, England
[3] Goethe Univ, Univ Hosp Frankfurt, Univ Canc Ctr, Frankfurt, Germany
[4] Goethe Univ, Univ Hosp Frankfurt, Dept Med, Hematol Oncol, Frankfurt, Germany
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148724
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5012
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Bortezomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma patients: a real-world study of China
    Xu, Jingyu
    Yan, Wenqiang
    Fan, Huishou
    Liu, Jiahui
    Du, Chenxing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Qiu, Lugui
    An, Gang
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S159 - S159
  • [42] Treatment Patterns and Clinical Outcomes in High-Risk Multiple Myeloma Patients Carrying the 17p Deletion: A Multi-Center Retrospective Observational Study
    Cohen, Yael
    Gatt, Moshe E.
    Lavi, Noa
    Ganzel, Chezi
    Magen, Hila
    Avivi, Irit
    Tadmor, Tamar
    Suriu, Celia
    Dolberg, Osnat Jarchowsky
    Papushado, Amitai
    Trestman, Svetlana
    Ram, Ron
    BLOOD, 2016, 128 (22)
  • [43] Lenalidomide and Low-dose Dexamethasone for Treatment of Relapsed/Refractory Multiple Myeloma: Real-world Treatment Patterns from the PREAMBLE Study
    Goldschmidt, Hartmut
    Cook, Gordon
    Kuter, David
    Vij, Ravi
    Popov, Sergey
    Zyczynski, Teresa
    Davis, Catherine
    Durie, Brian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E126 - E127
  • [44] Real-world treatment patterns and clinical outcomes in EGFR-mutant locally advanced lung adenocarcinoma: A multi-center cohort study
    Bi, Nan
    Xu, Kunpeng
    Ge, Hong
    Chen, Ming
    Mingyan, E.
    Zhang, Li
    Cao, Jianzhong
    Zhang, Xu
    Ding, Xiao
    Xia, Bing
    Zhao, Lujun
    Han, Lijie
    Li, Jiancheng
    Hu, Chen
    Wang, Luhua
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (01): : 65 - 71
  • [45] Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study
    McDaniel, Brandon T.
    Cornet, Victor
    Carroll, Jeanne
    Chrones, Lambros
    Chudzik, Joseph
    Cochran, Jeanette
    Guha, Shion
    Lawrence, Debra F.
    McCue, Maggie
    Sarkey, Sara
    Lorenz, Betty
    Fawver, Jay
    BMC PSYCHIATRY, 2023, 23 (01)
  • [46] Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study
    Brandon T. McDaniel
    Victor Cornet
    Jeanne Carroll
    Lambros Chrones
    Joseph Chudzik
    Jeanette Cochran
    Shion Guha
    Debra F. Lawrence
    Maggie McCue
    Sara Sarkey
    Betty Lorenz
    Jay Fawver
    BMC Psychiatry, 23
  • [47] Real-world treatment patterns and outcomes of triple-exposed multiple myeloma patients treated in community oncology practices in the United States.
    Smith, Robert
    Xue, Mei
    Dorrow, Natalie
    Varughese, Prateesh
    Hogea, Cosima
    Buckingham, Trudy
    Sansbury, Leah
    Ferrante, Shannon
    Maiese, Eric M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Lenalidomide versus Thalidomide or Bortezomib as maintenance regimen for non-transplant patients with multiple myeloma: multi-center real world experiences in China
    Zhuang, Zhe
    Shi, Lei
    Tian, Ying
    Zou, Dongmei
    Feng, Ru
    Dong, Fei
    Ma, Yanping
    Yu, Hong
    Tian, Wei-wei
    Liu, Shuangjiao
    Ma, Liang-Ming
    Fu, Rong
    Jing, Hongmei
    Liu, Hui
    Sun, Wanling
    Chen, Wenming
    Wu, Yin
    Bao, Li
    Zhuang, Junling
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S112 - S113
  • [49] Characteristics, Treatment Patterns, and Outcomes of Patients with Multiple Myeloma Retreated with Daratumumab in Real-World Clinical Practice in the USA
    Ailawadhi, Sikander
    Larson, Sarah M.
    Ferrante, Shannon
    Rafalko, Nicole
    Gupta-Werner, Niodita
    Harper, Jennifer S.
    Medhekar, Rohan
    Armoon, Marjohn
    Cortoos, Annelore
    Kaila, Shuchita
    Atrash, Shebli
    BLOOD, 2024, 144 : 2381 - 2382
  • [50] Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States
    Varughese, Prateesh
    Smith, Robert
    Xue, Mei
    Dorrow, Natalie
    Hogea, Cosmina
    Maiese, Eric. M.
    Buckingham, Trudy
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (01) : 65 - 74
12345